Viropil is prescribed by an infectious disease specialist or an AIDS center specialist for the treatment of patients with the following conditions: 🔹 Treatment of HIV-1 infection in adults and adolescents (weighing more than 40 kg). 🔹 Used as both starting therapy (for those who have not previously taken ART) and to replace current treatment regimens when indicated.

Dosage and administration

Sales Form: 1 bottle contains 30 tablets, designed for a one-month supply.⚠️ INSTRUCTIONS FOR USE: Dosage Regimen: The recommended dose is 1 tablet once daily. Method of Administration: The tablet should be swallowed whole with water. It can be taken with or without food, but it is advisable to do so at the same time every day to maintain a stable drug concentration. Important: Do not miss doses. Consistency is the key to successful viral suppression and the prevention of resistance. Storage: Store in a dry place at temperatures up to 30°C, in the tightly closed original packaging.

⛔ Hypersensitivity: Allergy to dolutegravir, lamivudine, tenofovir, or any excipients. ⛔ Drug Interaction: Co-administration with dofetilide (an anti-arrhythmic drug) is strictly prohibited. ⛔ Renal Impairment: Not recommended for patients with a creatinine clearance of less than 50 mL/min (due to the fixed dose of tenofovir). ⛔ Pregnancy and Lactation: The decision to take the drug is made only by a doctor after assessing risks and benefits. Breastfeeding is not recommended for HIV-positive individuals.

Most patients tolerate Viropil well; however, temporary effects may occur at the start of therapy: 🧠 Nervous System: Insomnia, headache, unusual dreams, dizziness. 🤢 GI Tract: Nausea, diarrhea, occasionally vomiting or abdominal discomfort. 🧪 Blood Counts: Rarely — increased creatinine or liver enzymes levels. 🦴 Bone Tissue: Long-term use of tenofovir may carry a risk of decreased bone mineral density. 🏃♂️ General: Fatigue, skin rash.

Viropil — Lamivudine 50 мг / 300 мг / 300 мг, 30 pcs, Emcure

100% original product

Active ingredient

Lamivudine Dolutegravir Tenofovir Disoproxil Fumarate

Manufacturer

Emcure

Dosage 50 мг / 300 мг / 300 мг

Dosage form Tablets

Tablets per pack 30

Viropil Tablets — Dolutegravir, Lamivudine, Tenofovir (30 Tablets)

Name: Viropil
Brand: Emcure
SKU: PROD-261
Price: 2528 UAH
Availability: InStock

2528₴ ~~2661₴~~ -5%

Viropil is a highly effective combined antiretroviral drug (ART) for the treatment of HIV infection. It is a "three-in-one" regimen that combines three powerful components in a single tablet: Dolutegravir (50 mg), Lamivudine (300 mg), and Tenofovir Disoproxil Fumarate (300 mg). This combination (DTG/3TC/TDF) is recommended by the World Health Organization (WHO) as the preferred first-line therapy regimen.

Manufacturer: Emcure Pharmaceuticals. Viropil is a high-quality generic that provides complete viral suppression, is convenient to use, and has a high genetic barrier to the development of resistance (viral escape).

Key Features:

✅ Full Treatment Cycle: One tablet contains the full daily dose of medication required for virus control.
✅ Modern Formula: The included dolutegravir (integrase inhibitor) allows for the fastest possible reduction of viral load to an undetectable level.
✅ High Safety Profile: The drug is well-tolerated by most patients during long-term use.

Viropil is prescribed by an infectious disease specialist or an AIDS center specialist for the treatment of patients with the following conditions:

🔹 Treatment of HIV-1 infection in adults and adolescents (weighing more than 40 kg).
🔹 Used as both starting therapy (for those who have not previously taken ART) and to replace current treatment regimens when indicated.

Sales Form: 1 bottle contains 30 tablets, designed for a one-month supply.

⚠️ INSTRUCTIONS FOR USE:

Dosage Regimen: The recommended dose is 1 tablet once daily.
Method of Administration: The tablet should be swallowed whole with water. It can be taken with or without food, but it is advisable to do so at the same time every day to maintain a stable drug concentration.
Important: Do not miss doses. Consistency is the key to successful viral suppression and the prevention of resistance.
Storage: Store in a dry place at temperatures up to 30°C, in the tightly closed original packaging.

⛔ Hypersensitivity: Allergy to dolutegravir, lamivudine, tenofovir, or any excipients.
⛔ Drug Interaction: Co-administration with dofetilide (an anti-arrhythmic drug) is strictly prohibited.
⛔ Renal Impairment: Not recommended for patients with a creatinine clearance of less than 50 mL/min (due to the fixed dose of tenofovir).
⛔ Pregnancy and Lactation: The decision to take the drug is made only by a doctor after assessing risks and benefits. Breastfeeding is not recommended for HIV-positive individuals.

Most patients tolerate Viropil well; however, temporary effects may occur at the start of therapy:

🧠 Nervous System: Insomnia, headache, unusual dreams, dizziness.
🤢 GI Tract: Nausea, diarrhea, occasionally vomiting or abdominal discomfort.
🧪 Blood Counts: Rarely — increased creatinine or liver enzymes levels.
🦴 Bone Tissue: Long-term use of tenofovir may carry a risk of decreased bone mineral density.
🏃‍♂️ General: Fatigue, skin rash.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 18.04.2026